Table IV.

Univariate analysis and multivariate analysis

	Univariate analysis			Multivariate analysis
Parameter	OR	95% CI	P	Adj. OR	95% CI	P
Age	1.14	1.11–1.18	<0.001	1.01	0.94–1.08	0.826
Sexa	0.75	0.52–1.09	0.135	–	–	–
Allergy	2.99	2.04–4.39	<0.001	2.11	0.75–5.95	0.158
Cumulative allergy	1.27	1.15–1.39	<0.001	0.92	0.65–1.30	0.625
Baseline PROMb
mHHSc	0.999	0.98–1.018	0.900	–	–	–
HOS-ADLd	0.997	0.983–1.012	0.723	–	–	–
HOS-SSe	0.998	0.987–1.009	0.727	–	–	–
iHOT-33f	1.000	0.985–1.016	0.992	–	–	–
Failure to achieve MCIDg ≤12 months post-op
mHHS	5.94	3.07–11.47	<0.001	3.09	1.15–8.32	0.026
HOS-ADL	4.75	2.44–9.23	<0.001	3.18	1.11–9.14	0.032
HOS-SS	3.36	1.67–6.76	<0.001	0.88	0.30–2.60	0.815
iHOT-33	2.81	1.38–5.72	0.004	0.85	0.32–2.23	0.742
Intra-op procedures
Labral repair	0.42	0.24–0.72	0.002	0.70	0.07–6.93	0.759
Cam decompression	0.58	0.28–1.18	0.132	–	–	–
Rim decompression	0.94	0.55–1.59	0.805	–	–	–

^aCalculated as risk of being male.

^bPatient reported outcome measure (PROM).

^cModifed Harris Hip Score (mHHS).

^dHip Outcome Score—Activities of Daily Living (HOS-ADL).

^eHip Outcome Score—Sports specific (HOS-SS).

^f33-item international Hip Outcome Tool (iHOT-33).

^gMinimal Clinically Important Difference.